**CERTIFICATION**


**OF
      CHIEF EXECUTIVE OFFICER**


**AND
      CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      302 OF THE SARBANES-OXLEY ACT OF 2002**




We,
      Dr.
      Richard Amy and Henry Val, certify that:




1.
      I have
      reviewed this Form 10-KSB of New Life Scientific, Inc.;




2.
            Based
                on my knowledge, this report does not contain any untrue statement
                of a
                material fact or omit to state a material fact necessary to make
                the
                statements made, in light of the circumstances under which such statements
                were made, not misleading with respect to the period covered by this
                report;3.
            Based
                on my knowledge, the financial statements, and other financial information
                included in this report, fairly present in all material respects
                the
                financial condition, results of operations and cash flows of the
                small
                business issuer as of, and for, the periods present in this report;4.
            The
                small business issuer’s other certifying officer(s) and I are responsible
                for establishing and maintaining disclosure controls and procedures
                (as
                defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
                control over financial reporting (as defined in Exchange Act Rules
                13-a-15(f) and 15d-15(f)) for the small business issuer and have:




(a)
            Designed such disclosure controls and procedures,
      or caused such disclosure controls and procedures to be designed under our
      supervision, to ensure that material information relating to the small business
      issuer, including its consolidated subsidiaries, is made known to us by others
      within those entities, particularly during the period in which this report
      is
      being prepared;




(b)
           Designed such internal control over financial
      reporting, or caused such internal control over financial reporting to be
      designed under our supervision, to provide reasonable assurance regarding there
      liability of financial reporting and the preparation of financial statements
      for
      external purposes in accordance with generally accepted accounting principals;




(c)
            Evaluated the effectiveness of the small business
      issuer’s disclosure controls and procedures and presented in this report our
      conclusions about the effectiveness of the disclosure controls and procedures,
      as of the end of the period covered by this report based on such evaluation;
      and




(d)
           Disclosed in this report any change in the small
      business issuer’s internal control over financing reporting that occurred during
      the small business issuer’s most recent fiscal quarter (the small business
      issuer’s fourth fiscal quarter in the case of an annual report) that has
      materially affected, or is reasonably likely to materially affect ,the small
      business issuer’s internal control over financial reporting; and




5.
            The
                small business issuer’s other certifying officer(s) and I have disclosed,
                based on our most recent evaluation of internal control over financial
                reporting, to the small business issuer’s auditors and the audit committee
                of the small business issuer’s board of directors (or persons performing
                the equivalent functions):




(a)
            All significant deficiencies and material
      weaknesses in the design or operation of internal control over financial
      reporting which are reasonably likely to adversely affect the small business
      issuer’s ability to record, process, summarize and report financial information;
      and




(b)
            Any fraud, whether or not material, that involved
      management or other employees who have a significant role in the small business
      issuer’s internal control over financial reporting.




Date:
      April 8, 2008





*/s/
                Dr Richard Amy*
            
            */s/
                Henry Val*Dr
                Richard Amy
            
            Henry
                ValChief
                Executive Officer
            
            Chief
                Financial Officer